Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Camzyos (mavacamten)
.
Show all posts
Showing posts with label
Camzyos (mavacamten)
.
Show all posts
Saturday, June 11, 2022
FDA Approves Camzyos (mavacamten) for the Treatment of Symptomatic NYHA Class II-III Obstructive Hypertrophic Cardiomyopathy
›
In continuation of my update on mavacamten Bristol Myers Squibb (NYSE: BMY) announced the U.S. Food and Drug Administration (FDA) approval...
›
Home
View web version
